Loading...
Harvard Bioscience, Inc.
HBIO•NASDAQ
Healthcare
Medical - Instruments & Supplies
$0.56
$-0.01(-0.93%)
Harvard Bioscience, Inc. (HBIO) Financial Performance & Income Statement Overview
Review Harvard Bioscience, Inc.’s income statement, balance sheet, and cash flow reports with annual and quarterly breakdowns.
Revenue Growth
-16.14%
↓ 16.14%
Operating Income Growth
-427.93%
↓ 427.93%
Net Income Growth
-263.25%
↓ 263.25%
Operating Cash Flow Growth
-89.73%
↓ 89.73%
Operating Margin
-47.88%
↓ 47.88%
Gross Margin
55.63%
↑ 55.63%
Net Profit Margin
-63.52%
↓ 63.52%
ROE
-110.18%
↓ 110.18%
ROIC
-180.85%
↓ 180.85%
Harvard Bioscience, Inc. (HBIO) Income Statement & Financial Overview
Review Harvard Bioscience, Inc.'s (HBIO) income statement with detailed quarterly and annual figures.
| Metric | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 |
|---|---|---|---|---|
| Revenue | $21.97M | $23.10M | $24.51M | $28.15M |
| Cost of Revenue | $9.21M | $11.21M | $11.07M | $13.21M |
| Gross Profit | $12.77M | $11.89M | $13.44M | $14.94M |
| Gross Profit Ratio | $0.58 | $0.51 | $0.55 | $0.53 |
| R&D Expenses | $2.57M | $2.63M | $2.88M | $3.15M |
| SG&A Expenses | $10.56M | $11.08M | $11.87M | $11.51M |
| Operating Expenses | $14.64M | $13.71M | $14.75M | $14.66M |
| Total Costs & Expenses | $23.84M | $24.92M | $25.82M | $27.87M |
| Interest Income | $0.00 | $0.00 | $0.00 | $0.00 |
| Interest Expense | $856000.00 | $749000.00 | $751000.00 | $794000.00 |
| Depreciation & Amortization | $1.81M | $1.76M | $1.74M | $1.77M |
| EBITDA | -$1.87M | -$773000.00 | -$2.28M | $1.46M |
| EBITDA Ratio | -$0.09 | -$0.003 | $0.02 | $0.07 |
| Operating Income | -$1.87M | -$1.82M | -$1.31M | $282000.00 |
| Operating Income Ratio | -$0.09 | -$0.08 | -$0.05 | $0.01 |
| Other Income/Expenses (Net) | -$2.62M | -$1.21M | -$2.21M | -$1.39M |
| Income Before Tax | -$4.49M | -$3.28M | -$4.48M | -$1.10M |
| Income Before Tax Ratio | -$0.20 | -$0.14 | -$0.18 | -$0.04 |
| Income Tax Expense | $311000.00 | -$353000.00 | $210000.00 | $715000.00 |
| Net Income | -$4.80M | -$2.93M | -$4.69M | -$1.82M |
| Net Income Ratio | -$0.22 | -$0.13 | -$0.19 | -$0.06 |
| EPS | -$0.11 | -$0.07 | -$0.11 | -$0.04 |
| Diluted EPS | -$0.11 | -$0.07 | -$0.11 | -$0.04 |
| Weighted Avg Shares Outstanding | $43.61M | $43.49M | $43.40M | $42.71M |
| Weighted Avg Shares Outstanding (Diluted) | $43.61M | $43.49M | $43.40M | $42.71M |
Unlock 25+ Years of Financial Data
Get access to extended historical data, advanced metrics, and more with our premium plan